Defibrillator Market Size and Companies (2026-2035)

Revenue, 2025

USD 8.6 Billion

Forecast, 2035

USD 18.8 Billion

CAGR, 2026-2035

8.14%

Report Coverage

Global

Defibrillator Market Trends for 2026

The global defibrillator market size was estimated at USD 8.6 billion in 2025 and is predicted to increase from USD 9.29 billion in 2026 to approximately USD 18.8 billion by 2035, expanding at a CAGR of 8.14% from 2026 to 2035.

The defibrillator market is growing due to the increasing applications in sudden cardiac arrest (SCA), ventricular fibrillation (VF), pulseless ventricular tachycardia (VT), and wearable cardioverter defibrillators (WCDs)

Key Takeaways

• Defibrillator market to crossed USD 9.29 billion by 2026.
• Market projected at USD 18.8 billion by 2035.
• CAGR of 8.14% expected in between 2026 to 2035.
• North America dominated the defibrillator Market in 2025.
• Asia Pacific is expected to grow at the fastest CAGR in the market during the forecast period.
• By product, the implantable cardioverter defibrillators (ICDs) segment dominated the market in 2025.
• By product, the external defibrillators segment is expected to grow at the fastest CAGR in the market during the forecast period.
• By end user, the hospitals segment led the market in 2025.
• By end user, the public access market segment is expected to grow at the fastest CAGR in the market during the forecast period.

Defibrillator Market Overview: What is Brain Cancer?

Defibrillators are devices that apply an electric current or charge to the heart to restore a standard heartbeat. Some implantable or wearable defibrillators fix certain dangerous arrhythmias, which are difficulties with the rhythm of the heartbeat. Defibrillators have various applications, based on the type. Automated external defibrillators (AEDs) are found in major public spaces. They save the lives of people who are in heart attack.

Cardiovascular Diseases in 2025

How is AI Governing the Defibrillator Market?

The integration of AI-driven technology into defibrillators drives the growth of the market, as AI-driven technology is used to calculate optimal geographical location and possible patrols to allow high access to automated external defibrillators. AI-based technology is enhancing the precision of heart rhythm readings, improving decision-making processes, and offering real-time feedback. AI-based systems offer immediate guidance on chest compression rate, depth, and recoil, enhancing resuscitation quality and consistency.

Future Outlook & Trends in the Defibrillator Market

Smart & Connected Devices:

The incorporation of AI and advanced algorithms is modernizing defibrillator devices monitor and respond to asymmetrical cardiac rhythms. These novelties not only improve device efficacy but also enhance patient outcomes by reducing unnecessary interventions.

Miniaturization & Leadless Technology:

Innovation in battery technology and deep miniaturisation of electronics present the opportunity to implant the whole pacemaker system in the ventricle.

Novel Approaches:

The development in defibrillator design shows significant progress in the management of cardiac arrhythmias and the prevention of SCA. By focusing on improving safety and efficacy, these new strategies address the challenges of conventional tools and prioritize patient compliance.

Quick Facts Table

Segmentation Analysis

Product Insights

Which Product Led the Defibrillator Market in 2025?

In 2025, the implantable cardioverter defibrillators (ICDs) segment held the dominant market share, as ICDs avoid arrhythmic deaths, but they also affect quality of life (QOL) due to device-associated challenges. An ICD lowers the challenges of sudden death from cardiac arrest more than medicine. It is intended to treat dangerously rapid heart rates. It incessantly monitors the heart and restores it to its normal heart rate.

External Defibrillators

Whereas the external defibrillators segment is the fastest-growing in the market, as this device provides a fully robotic life-saving emergency therapy rapidly and is operable by any layperson. An automated exterior defibrillator increases the chance of saving the life of an SCA victim by 75%. The machineries are completely automated, portable, and analyzes the heart for shock rhythms. They are intended to give shocks robotically, and the rescuer does not press any button.

End-use Insights

Why did the Hospitals Segment Dominate the Market in 2025?

The hospitals segment is dominant in the defibrillator market in 2025, as defibrillators reduce the challenges of sudden death in people who have a known arrhythmia or a high risk of a life-threatening arrhythmia from causes like genetic diseases, cardiac failure, or a prior cardiac arrest. Major hospitals and medical clinics employ the use of defibrillators on a routine basis as they strengthen an patients chance of survival.

Public Access Market

Whereas the public access market segment is the fastest growing in the market, as public automated external defibrillator (AED) defibrillation has increased survival rates as compared with defibrillation by EMS; this was most probably attributable to a much lower time to defibrillation. Public access defibrillation is specifically significant in witnessed cardiac arrests that happen in public places.

Regional Insights

How did North America Dominate the Market in 2025?

In 2025, North America led the defibrillator market, as growing cases of cardiac diseases driven by continuing rises in high blood pressure, obesity, and other major complicating factors, cardiac disease continues to kill more people, according to the American Heart Association. In the United States, people have a heart attack each 40 seconds; each year, around 805,000 people in the United States have a heart attack. The presence of industry leaders like Medtronic, Abbott, Boston Scientific Corporation, and Stryker, which drives the growth of the market.

For Instance,

• In October 2025, Philips and Medic Assist GmbH announced a strategic partnership to integrate Philips Automated External Defibrillators (AEDs) into Securitas’ guarding and security solutions.

U.S. Market Trends

Increasing cases of cardiovascular diseases (CVD) are largely attributed to unhealthy lifestyle factors like alcohol consumption, physical inactivity, smoking, and unhealthy food habits. U.S. and international sites are to make and bolster the guideline infrastructure to help population-based heart disease prevention, which drives the growth of the market.

Asia Pacific: Increasing Burden of Cardiovascular Disease

Asia Pacific is set to experience rapid growth in the defibrillator market due to the rapidly increasing burden of cardiovascular disease (CVD) in this region. The number of aging people in the Asia-Pacific will triple, reaching 1.3 billion by 2050, which increases the demand of defibrillator. Growing disposable incomes are driving healthcare investment, also increasing the burgeoning pow middle class in this region, which contributes to the growth of the market.

For Instance,

• In March 2025, Medtronic Japan Co., Ltd. announced that the Aurora EV-ICDTM MRI device and the Epsila EVTM MRI Lead, which are used in the treatment of ventricular arrhythmias, were launched successively in Japan.

India Market Trends

In India, increasing Government initiatives and growing public awareness campaigns support bridging the gap and encourage preventive care. India's increasing cardiac cases highlight an emergency requirement for better medical care approaches, preventive awareness, and accessible treatment. Cardiac health awareness supports lowering disease rates and enhancing treatment achievement. Early identification and better lifestyle habits prevent severe conditions, which drives the growth of the market.

Europe: Increasing Cases of Cardiovascular Diseases

Europe is experiencing substantial growth in the defibrillator market, as heart diseases are the leading cause of death in Europe, accounting for over 42.5% of all deaths per year, which increases the demand of defibrillator. The growing installation of automated external defibrillators (AEDs) in the workplace in Europe, which drives the growth of the market.

UK Market Trends

Cardiovascular disease (CVD) is the most usual causes of death in the UK, and more than 6 million people live with CVD. Medical care expenses relating to CVD are estimated at £7.4 billion per year, which drives the growth of the market.

Value Chain Analysis – Defibrillator Market

R&D:

• Research and development for defibrillators is a multi-stage process that combines biomedical engineering, electrical design, and rigorous clinical validation to safeguard life-saving reliability.
• Key Players: Medtronic and Abbott

Manufacturing Processes:

• Defibrillator manufacturing includes an integration of precision electronics assembly for the device itself and, particularly, sterile, material-science-based technology for the electrode pads.
• Key Players: Boston Scientific and Stryker

Patient Services:

• Patient services involved in defibrillators involves wide range of care, including preliminary tests, surgical implantation, and long-term monitoring, often with help from a dedicated medical care team.
• Key Players: ZOLL Medical and Biotronik

Latest Updates of Key Players in the Defibrillator Market

SWOT Analysis

Strengths

• Defibrillator offers a rapid response, simple maintenance, enhanced survival rates, and lowers the challenges of long-term complications.
• Modern defibrillators in the workplace, like AEDs, are intended for simple use, enabling immediate response without extensive training.

Weaknesses

• Possible challenges of implantable cardiac defibrillators are swelling, infection, bleeding, or bruising at the implant site.
• Movement of the tools or leads, which could cause a rip or cut in the heart muscle.

Opportunities

• The EV-ICD is an evolving novel device that does not need intravascular access, maintains efficient defibrillation, and has ATP and pause-prevention pacing abilities.
• Defibrillator technology is emerging significantly, enhancing both function and implantation processes. The integration of an Extravascular Implantable Cardioverter Defibrillator (EV ICD) with a CCM device give best output.

Threat

• The complexes of living with an implantable cardioverter defibrillator include living with fear, challenges about the future, concerns related to tool malfunction, fearing death during the shock, and pain due to the shock.

Recent Developments in the Defibrillator Market

•  In January 2026, Medtronic commercially launched the OmniaSecure defibrillation lead in the USA, with the first cases being performed at hospitals across the country.
• In December 2025, CHELMSFORD, MASS. ZOLL, an Asahi Kasei company that manufactures medical devices and related software solutions, announced the U.S. launch of the next-generation LifeVest wearable cardioverter defibrillator (WCD).
• In September 2025, Safe Life, a leading provider of life-saving solutions with operations across North America, Europe, and Asia, announced the acquisition of AED Brands, a Georgia-based company specializing in sales of automated external defibrillators (AEDs), consumables for AEDs, and services related to life-saving readiness.

Segments Covered in the Report

By Product

• Implantable Cardioverter Defibrillators (ICD)
  • S-ICD
  • T-ICD
    • Single Chamber
    • Dual Chamber
    • CRT-D
• External Defibrillators (ED)
  • Manual ED
  • Automated ED
  • Wearable Cardioverter Defibrillators

By End User

• Hospital
• Pre-hospital
• Public Access Market
• Alternate Care Market
• Home Healthcare

Regional Outlook

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait